Laser Focus World is an industry bedrock—first published in 1965 and still going strong. We publish original articles about cutting-edge advances in lasers, optics, photonics, sensors, and quantum technologies, as well as test and measurement, and the shift currently underway to usher in the photonic integrated circuits, optical interconnects, and copackaged electronics and photonics to deliver the speed and efficiency essential for data centers of the future.

Our 80,000 qualified print subscribers—and 130,000 12-month engaged online audience—trust us to dive in and provide original journalism you won’t find elsewhere covering key emerging areas such as laser-driven inertial confinement fusion, lasers in space, integrated photonics, chipscale lasers, LiDAR, metasurfaces, high-energy laser weaponry, photonic crystals, and quantum computing/sensors/communications. We cover the innovations driving these markets.

Laser Focus World is part of Endeavor Business Media, a division of EndeavorB2B.

Laser Focus World Membership

Never miss any articles, videos, podcasts, or webinars by signing up for membership access to Laser Focus World online. You can manage your preferences all in one place—and provide our editorial team with your valued feedback.

Magazine Subscription

Can you subscribe to receive our print issue for free? Yes, you sure can!

Newsletter Subscription

Laser Focus World newsletter subscription is free to qualified professionals:

The Daily Beam

Showcases the newest content from Laser Focus World, including photonics- and optics-based applications, components, research, and trends. (Daily)

Product Watch

The latest in products within the photonics industry. (9x per year)

Bio & Life Sciences Product Watch

The latest in products within the biophotonics industry. (4x per year)

Laser Processing Product Watch

The latest in products within the laser processing industry. (3x per year)

Get Published!

If you’d like to write an article for us, reach out with a short pitch to Sally Cole Johnson: [email protected]. We love to hear from you.

Photonics Hot List

Laser Focus World produces a video newscast that gives a peek into what’s happening in the world of photonics.

Following the Photons: A Photonics Podcast

Following the Photons: A Photonics Podcast dives deep into the fascinating world of photonics. Our weekly episodes feature interviews and discussions with industry and research experts, providing valuable perspectives on the issues, technologies, and trends shaping the photonics community.

Editorial Advisory Board

  • Professor Andrea M. Armani, University of Southern California
  • Ruti Ben-Shlomi, Ph.D., LightSolver
  • James Butler, Ph.D., Hamamatsu
  • Natalie Fardian-Melamed, Ph.D., Columbia University
  • Justin Sigley, Ph.D., AmeriCOM
  • Professor Birgit Stiller, Max Planck Institute for the Science of Light, and Leibniz University of Hannover
  • Professor Stephen Sweeney, University of Glasgow
  • Mohan Wang, Ph.D., University of Oxford
  • Professor Xuchen Wang, Harbin Engineering University
  • Professor Stefan Witte, Delft University of Technology

New Research Links Psychiatric Hospitalization to Much Higher Risks of Premature Death and Suicide After Discharge, CCHR Warns

A growing body of evidence suggests that psychiatric hospitalization itself may be a major risk factor for suicide and other harms to patients’ mental health, especially for those admitted against their will. Citizens Commission on Human Rights is calling on Congress to investigate.

Patients discharged from psychiatric hospitalization face a risk of premature death eight times higher than in the general population, and a risk of suicide 33 times higher, with an even greater risk of suicide in the first year after discharge, a new study has found. The study adds to a growing body of evidence indicating that psychiatric hospitalization does not decrease, but can actually increase the risk of suicide and other harmful outcomes for patients, especially for those receiving treatment against their will. 

Researchers in Spain, Norway and the United States examined medical records of over 49,000 psychiatric patients in Spain who had received psychiatric hospitalization from 2014-2018. They found that in a follow-up period of one to six years after discharge, 1 in 20 patients (5%) died prematurely (before the age of 70), with the risk of premature death almost eight times higher than in the general population. 

Of even greater concern is the finding that 1 in 10 (10%) committed acts of self-harm, including attempted suicide, after discharge from psychiatric hospitalization, while 1 in 100 (1%) died from suicide. The risk of suicide was 33 times greater than in the general population during the study’s follow-up period, with an even higher 54 times greater risk in the first year post-discharge.

The study findings indicate that “individuals discharged from psychiatric inpatient care are a vulnerable population for premature death and suicidal behavior,” wrote lead researcher Philippe Mortier, Ph.D., at the Hospital del Mar Research Institute in Barcelona, Spain. The study was published in JAMA Psychiatry.

Almost one in four (24%) of the patients hospitalized during the period under study had prior psychiatric hospitalizations, another indication of the inadequacy of psychiatric treatment.

These findings are consistent with other studies which have found that admission to a psychiatric facility is highly associated with the risk of dying from suicide. A study earlier this year pinpointed the first few days and weeks after discharge as a period of extremely high risk of suicide for patients who received psychiatric hospitalization for depression. Even many years after discharge, previously hospitalized psychiatric patients have high suicide rates compared to the general population, another study found.

People admitted to a psychiatric facility against their will are even more likely to attempt suicide after discharge than psychiatric patients who were not forcibly admitted, according to research findings.

Antidepressants and other psychiatric drugs used as treatment during hospitalization are also linked to suicidal behavior. Researchers conducting a 2019 re-analysis of safety summaries in the U.S. Food and Drug Administration (FDA) database found evidence that depressed patients receiving antidepressants attempted suicide at a rate 2.5 times higher than those who received a placebo.

“With substantial evidence that psychiatric hospitalization and treatment result in significant harm to many patients, especially increasing the risk of suicide, the Citizens Commission on Human Right is calling on Congress to investigate in-patient psychiatric treatment,” said Anne Goedeke, president of the organization’s National Affairs Office. 

“The current standard treatment in psychiatric facilities is not only failing to decrease the rate of suicide in the U.S., but it is increasing it at a cost of human lives. This must stop.”

About the company: The Citizens Commission on Human Rights was co-founded in 1969 by members of the Church of Scientology and the late psychiatrist and humanitarian Thomas Szasz, M.D., recognized by many academics as modern psychiatry’s most authoritative critic, to eradicate abuse and restore human rights and dignity to the field of mental health.

Contact Info:
Name: Anne Goedeke
Email: Send Email
Organization: Citizens Commission on Human Rights, National Affairs Office
Address: Washington, DC
Website: https://CCHRNational.org

Release ID: 89134534

Should you identify any discrepancies, concerns, or inaccuracies in the content provided in this press release or require assistance with a press release takedown, we strongly urge you to notify us promptly by contacting error@releasecontact.com (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our responsive team is committed to addressing your concerns within 8 hours by taking necessary actions to resolve identified issues diligently or guiding you through the necessary steps for removal. Our dedication lies in providing accurate and reliable information.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.